ClinicalTrials.gg
Sign In

Vaginitis clinical trials

The registry lists 98 studies for Vaginitis across more than 10 countries. 12 are recruiting or about to start. 57 of them are mainly about Vaginitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26. Counting its 5 narrower conditions too, such as Vaginosis, Bacterial: 444 studies, 64 open.

Get an email when these change. Save the Vaginitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
64
Status unknown
13
Not yet recruiting
7
Withdrawn
5
Recruiting
5
Terminated
3

Phase

Phase 3
17
Phase 2
12
Phase 4
10
Phase 1
6
Early Phase 1
2

Where

United States
38
Israel
7
China
5
Turkey
4
Egypt
4
Canada
3

Who runs them

Assiut University (3) · Carmel Medical Center (3) · Curatek Pharmaceuticals, LLC (3) · Gedea Biotech AB (3) · CONRAD (2) · Lumara Health, Inc. (2) · Laboratoire Innotech International (2) · Perfect Care Distribution (2)

What is being tested here

Drugs under test in Vaginitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Estradiol103
Metronidazole025
TOL-463002
Clindamycin phosphate022
Clindamycin022
Doxycycline001
Ibrexafungerp011
Lactobacillus plantarum001
Lactobacillus crispatus CTV-05001
Imiquimod001

Coming up

2phase 3 studies under way
2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Who these studies take

Of the 5 Vaginitis studies recruiting now, 2 (40%) set no upper age limit and 3 (60%) stop at 75 or younger. 0 (0%) take children under 18. 5 (100%) are for women only and 0 (0%) for men only; 2 (40%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
100 (0%)0 (0%)
184 (80%)0 (0%)
305 (100%)0 (0%)
405 (100%)0 (0%)
505 (100%)0 (0%)
652 (40%)0 (0%)
752 (40%)0 (0%)
852 (40%)0 (0%)

Across all 98 studies, recruiting or not: 56% stop at 75 or younger and 47% at 65; 15% take children; 98% are for women only and 0% for men only; 39% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vaginitis studies take

Of 22 interventional studies with no phase under Vaginitis, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo9–35 · 22 studies——
Observational19 mo4–50 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 98. Browse all 98 → or search them.